blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1371664

EP1371664 - WTI MODIFIED PEPTIDE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  14.11.2008
Database last updated on 06.07.2024
Most recent event   Tooltip22.10.2010Lapse of the patent in a contracting state
New state(s): GR
published on 24.11.2010  [2010/47]
Applicant(s)For all designated states
International Institute of Cancer Immunology, Inc.
13-9, Enoki-cho
Suita-shi, Osaka-fu / JP
[2006/40]
Former [2003/51]For all designated states
Sugiyama, Haruo
2-19-30, Senbanishi
Mino-shi, Osaka 562-0036 / JP
Inventor(s)01 / Sugiyama, Haruo
2-19-30, Senbanishi Minoo-shi
Osaka 562-0036 / JP
 [2008/02]
Former [2007/34]01 / Sugiyama, Haruo
Mino-shi
Osaka 562-0036 / JP
Former [2003/51]01 / see applicant
...
Representative(s)Wachenfeld, Joachim
Vossius & Partner
Postfach 86 07 67
81634 München / DE
[N/P]
Former [2006/23]Wachenfeld, Joachim
Vossius & Partner Postfach 86 07 67
81634 München / DE
Former [2003/51]Harding, Charles Thomas, et al
D. Young & Co. 21 New Fetter Lane
London EC4A 1DA / GB
Application number, filing date02708646.122.03.2002
[2003/51]
WO2002JP02794
Priority number, dateJP2001008325022.03.2001         Original published format: JP 2001083250
[2003/51]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO02079253
Date:10.10.2002
Language:EN
[2002/41]
Type: A1 Application with search report 
No.:EP1371664
Date:17.12.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 10.10.2002 takes the place of the publication of the European patent application.
[2003/51]
Type: B1 Patent specification 
No.:EP1371664
Date:09.01.2008
Language:EN
[2008/02]
Search report(s)International search report - published on:JP10.10.2002
(Supplementary) European search report - dispatched on:EP03.02.2006
ClassificationIPC:C07K14/82, A61K38/00, A61K39/00, A61P35/00, C07K7/04, C12N5/06, C07K7/06
[2006/12]
CPC:
C07K14/4748 (EP,BR,US); C07K14/82 (KR); A61P35/00 (EP);
A61P35/02 (EP); A61K2039/5154 (EP,BR,KR,US); A61K2039/5158 (EP,BR,KR,US);
A61K2039/53 (EP,BR,US); A61K39/00 (EP,BR,KR,US) (-)
Former IPC [2003/51]C07K14/82, A61K38/00, A61K39/00, A61P35/00, C07K7/04, C12N5/06
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/51]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:WTI-MODIFIZIERTES PEPTID[2003/51]
English:WTI MODIFIED PEPTIDE[2003/51]
French:PEPTIDE MODIFIE WT1[2003/51]
Entry into regional phase12.09.2003Translation filed 
15.09.2003National basic fee paid 
15.09.2003Search fee paid 
15.09.2003Designation fee(s) paid 
15.09.2003Examination fee paid 
Examination procedure22.04.2002Request for preliminary examination filed
International Preliminary Examining Authority: JP
15.09.2003Examination requested  [2003/51]
09.05.2006Despatch of a communication from the examining division (Time limit: M04)
15.09.2006Reply to a communication from the examining division
28.02.2007Despatch of a communication from the examining division (Time limit: M04)
16.04.2007Reply to a communication from the examining division
19.07.2007Communication of intention to grant the patent
22.11.2007Fee for grant paid
22.11.2007Fee for publishing/printing paid
Opposition(s)10.10.2008No opposition filed within time limit [2008/51]
Fees paidRenewal fee
15.09.2003Renewal fee patent year 03
11.03.2005Renewal fee patent year 04
13.03.2006Renewal fee patent year 05
29.03.2007Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT09.01.2008
BE09.01.2008
CY09.01.2008
DK09.01.2008
FI09.01.2008
NL09.01.2008
TR09.01.2008
LU22.03.2008
IE24.03.2008
MC31.03.2008
SE09.04.2008
GR10.04.2008
PT09.06.2008
[2010/47]
Former [2010/37]AT09.01.2008
BE09.01.2008
CY09.01.2008
DK09.01.2008
FI09.01.2008
NL09.01.2008
TR09.01.2008
LU22.03.2008
IE24.03.2008
MC31.03.2008
SE09.04.2008
PT09.06.2008
Former [2010/32]AT09.01.2008
BE09.01.2008
CY09.01.2008
DK09.01.2008
FI09.01.2008
NL09.01.2008
LU22.03.2008
IE24.03.2008
MC31.03.2008
SE09.04.2008
PT09.06.2008
Former [2009/33]AT09.01.2008
BE09.01.2008
CY09.01.2008
DK09.01.2008
FI09.01.2008
NL09.01.2008
IE24.03.2008
MC31.03.2008
SE09.04.2008
PT09.06.2008
Former [2009/08]AT09.01.2008
BE09.01.2008
DK09.01.2008
FI09.01.2008
NL09.01.2008
IE24.03.2008
MC31.03.2008
SE09.04.2008
PT09.06.2008
Former [2008/46]AT09.01.2008
BE09.01.2008
DK09.01.2008
FI09.01.2008
NL09.01.2008
MC31.03.2008
SE09.04.2008
PT09.06.2008
Former [2008/43]AT09.01.2008
BE09.01.2008
FI09.01.2008
NL09.01.2008
PT09.06.2008
Former [2008/42]AT09.01.2008
FI09.01.2008
NL09.01.2008
PT09.06.2008
Former [2008/39]AT09.01.2008
FI09.01.2008
NL09.01.2008
Former [2008/27]NL09.01.2008
Documents cited:Search[E]WO03028758  (SUGIYAMA HARUO [JP], et al) [E] 1-7 * the whole document *;
 [T]  - AKIHIRO TSUBOI ET AL, "ENHANCED INDUCTION OF HUMAN WT1-SPECIFIC CYTOTOXIC T LYMPHOCYTES WITH A 9-MER WT1 PEPTIDE MODIFIED AT HLA-A*2402-BINDING RESIDUES", CANCER IMMUNOLOGY AND IMMUNOTHERAPY, BERLIN, DE, (200212), vol. 51, no. 11-12, ISSN 0340-7004, pages 614 - 620, XP002961732

DOI:   http://dx.doi.org/10.1007/s00262-002-0328-9
International search[A]WO9638176  (KISHIMOTO TADAMITSU [JP], et al);
 [A]WO0006602  (SUGIYAMA HARUO [JP], et al);
 [X]WO0018795  (CORIXA CORP [US], et al);
 [X]WO0026249  (IMP COLLEGE INNOVATIONS LTD [GB], et al);
 [A]  - OKA Y. ET AL., "Cancer immunotherapy targeting wilms", J. IMMUNOL., (2000), vol. 164, pages 1773 - 1880, XP000890067
 [A]  - TADOKORO KEIKO, "Gan yokusei idenshi WT1 no kino hatsugen", GENDAI KAGAKU EXTRA ISSUE 33 'GAN IDENSHI KENKYU NO TENBO II', (1997), pages 92 - 98, XP002955873
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.